A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights

Significant improvements in the management of hepatocellular carcinoma (HCC) during the past three years have urged the timely update of clinical guidelines in China. In brief, aMAP score is newly recommended as an effective risk stratification tool to predict HCC occurrence especially for non-cirrh...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Di-Yang, Zhu, Kai, Ren, Zheng-Gang, Zhou, Jian, Fan, Jia, Gao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129899/
https://www.ncbi.nlm.nih.gov/pubmed/37124695
http://dx.doi.org/10.21037/hbsn-22-469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129899/
https://www.ncbi.nlm.nih.gov/pubmed/37124695
http://dx.doi.org/10.21037/hbsn-22-469

Ejemplares similares